EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Polyamine Metabolism in Human Intracellular Pathogens Colonizing Macrophages—Connecting the Dots Between Mycobacterium, Leishmania and Plasmodium

Sergii Krysenko

Pathogens · 09.11.2026 · 15 (11) · 1175

DOI: 10.3390/pathogens15111175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 09.11.2026. Verfasst von Sergii Krysenko. Die Arbeit nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polyamine metabolism has emerged as an important factor in pathogen survival, proliferation, virulence and persistence, highlighting polyamine-associated proteins and metabolic pathways as promising therapeutic targets. This is particularly relevant to major infectious diseases, including tuberculosis, malaria, leishmaniasis, and trypanosomiasis, in which pathogens exploit and remodel host cellular processes to evade immune responses and establish intracellular survival. Increasing evidence indicates that alterations in host–pathogen polyamine metabolism contribute to pathogen adaptation and persistence, providing opportunities for therapeutic intervention. Over the past decade, several components of polyamine biosynthesis, transport, and utilization have been identified and validated as potential drug targets in clinically relevant pathogens. Concurrently, advances in medicinal chemistry have led to the development of polyamine-derived compounds with enhanced specificity toward pathogen-associated polyamine proteins and metabolic pathways. These advancements have improved approaches to target-based drug discovery, which can be a novel complementary strategy to conventional antimicrobial development. This is particularly relevant in the context of the increasing prevalence of multidrug-resistant (MDR) pathogens. In this review, recent advances in the identification and validation of polyamine-related drug targets in pathogens causing tuberculosis, malaria, leishmaniasis, and trypanosomiasis are summarized. Furthermore, emerging strategies for the design and optimization of polyamine-derived therapeutic compounds, with a focus on their molecular targets, mechanisms of action, and potential for combating antimicrobial resistance, are discussed. Current challenges and future opportunities for targeting polyamine metabolism in the development of next-generation therapeutics are highlighted.:

Zitieren

APA

Krysenko, S. (2026). Targeting Polyamine Metabolism in Human Intracellular Pathogens Colonizing Macrophages—Connecting the Dots Between Mycobacterium, Leishmania and Plasmodium. Pathogens, 15(11), 1175. https://doi.org/10.3390/pathogens15111175

Vancouver

Krysenko S. Targeting Polyamine Metabolism in Human Intracellular Pathogens Colonizing Macrophages—Connecting the Dots Between Mycobacterium, Leishmania and Plasmodium. Pathogens. 2026;15(11):1175. doi:10.3390/pathogens15111175

BibTeX
@article{Krysenko2026,
  author = {Krysenko, Sergii},
  title = {Targeting Polyamine Metabolism in Human Intracellular Pathogens Colonizing Macrophages—Connecting the Dots Between Mycobacterium, Leishmania and Plasmodium},
  journal = {Pathogens},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1175},
  doi = {10.3390/pathogens15111175}
}
Kostenlos starten →